May 13, 2020
Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) has entered into an agreement with Canaccord Genuity.
May 6, 2020
Cardiol Therapeutics is pleased to announce the filing of a new patent application covering the use of cannabidiol (CBD) to...
April 1, 2020
Data Accepted for Presentation at the American College of Cardiology Annual Meeting
March 27, 2020
Cardiol Therapeutics Inc. filed its audited Year-end Financial Statements and Management's Discussion and Analysis for the year ended December 31,...
March 18, 2020
Cardiol Therapeutics Inc. has signed a supplier agreement to offer its pharmaceutically produced cannabidiol to Medical Cannabis by Shoppers.
March 5, 2020
Cardiol Therapeutics has received a No Objection Letter from Health Canada to conduct a Phase 1 study of its pharmaceutically...
January 15, 2020
Dalton Pharma Services, has received a three-year renewal and license amendment of its Cannabis Act Processing License from Health Canada.